An Alcohol Control Revealed Unequal Sensitivity in a Cannabis City-Driving Study
Two scoring methods applied to the same city-driving study did not detect the same drug effects. Neither found a significant THC-related change, but only the instructor’s retrospective method detected an alcohol effect. The alcohol control therefore exposed an important limitation in interpreting the other method’s negative result.
Two treatment groups, each with its own placebo comparison
The city-driving experiment in Robbe and O’Hanlon’s 1993 report enrolled separate marijuana and alcohol groups of sixteen adults each. Two participants were excluded from the marijuana analyses after neither THC nor its metabolite was found in their plasma samples, leaving fourteen in that group and sixteen in the alcohol group.
Each group underwent its active treatment and its corresponding placebo treatment on separate occasions. Participants did not all receive both drugs. The marijuana treatment targeted 100 micrograms THC per kilogram; estimated consumption averaged about 6.9 milligrams. The experiment did not test simultaneous cannabis and alcohol use.
Participants drove a fixed urban route with a safety instructor and a separate observer. Assessors were blinded to active-versus-placebo treatment and group membership. Driving commenced thirty minutes after smoking began in the marijuana group and forty-five minutes after drinking began in the alcohol group.
One method sampled particular actions
The observer used a structured approach that repeatedly scored defined behaviors at predetermined route locations. The scheme covered 156 possible observations, including mirror checks, path, speed and intersection behavior. Its total score was the percentage of observed items performed correctly.
This method found no significant mean drug-placebo change in either group. A negative THC result alone could therefore not demonstrate that the method reliably detected every relevant form of drug-related impairment: it also missed the alcohol-associated change detected by the other method.
The instructor’s broader score detected an alcohol effect
The instructor retrospectively scored a different, 108-item assessment. Under that method, alcohol reduced the total score by 6.8 percentage points on average, a significant change. Vehicle handling and action-in-traffic components also declined significantly.
The marijuana group’s total change was a nonsignificant decline of 0.7 percentage points. Importantly, the direct between-group comparison of total-score changes did not meet the conventional 0.05 threshold: its reported value was 0.065. Significant change in one group and nonsignificant change in another are not automatically a significant difference between groups.
One component, vehicle handling, did show a significant direct group difference. Keeping that component result separate from the total-score comparison preserves what the actual analyses established.
The THC result was bounded by the dose and task
The authors interpreted the low-dose THC findings as showing no impairment on their city-driving assessment. A careful application retains the limits: a small selected group, one THC level, a supervised route and the sensitivity of the particular measures. The report recommended city-driving research at higher THC doses.
THC significantly affected a laboratory steadiness measure despite the nonsignificant city-driving scores. This further illustrates that a functional result belongs to the specific task tested. A laboratory effect cannot simply be relabeled as a measured city-driving deficit, and a negative driving score cannot establish absence of every drug effect.
Do not relabel the alcohol specimen
The report’s chemical measurements were made in plasma. Mean measured plasma ethanol concentrations were 0.034 and 0.028 grams per 100 milliliters before and after driving. The authors inferred a possible peak during the drive; those observations should not be rewritten as a directly measured whole-blood concentration of exactly 0.04 throughout the test.
For a forensic review, ask whether the claimed conclusion matches the scoring system, comparator, dose and specimen actually studied. An active control helps evaluate sensitivity, but it cannot turn every nonsignificant comparison into proof of safety or equivalence.
Related: questions to ask before relying on cannabis tolerance testimony.
Primary research
Robbe HWJ, O’Hanlon JF. Marijuana and Actual Driving Performance. National Highway Traffic Safety Administration, November 1993. Report DOT HS 808 078. doi:10.21949/1525346.
